Abstract:Abstract Background Rapamycin is known to be effective in suppressing senescence and the senescence-associated secretory phenotype (SASP). Therefore, it is highly expected to represent an anti-aging drug. Its anti-aging effect has been demonstrated at the mouse individual level. However, there are not many clinical findings with respect to its activity in humans. Here, we aimed to clarify the effect of rapamycin on human endothelial cells (ECs) as an in vitro model of human blood vessels. Methods Over the course of oxidative stress-induced senescence using hydrogen peroxide, we examined the effect of rapamycin on human coronary artery ECs (HCAECs). Senescence was evaluated by detecting senescence-associated β-galactosidase (SA-β-Gal) activity and the real-time PCR analysis of p16 INK4a . Furthermore, expression levels of SASP factors were examined by real-time PCR and the expression of senescence-related antigens, such as intercellular adhesion molecule-1 (ICAM-1) and ganglioside GM1, were examined by fluorescence-activated cell sorting analysis and immunostaining. The inhibitory effect of rapamycin on mTOR signaling was examined by immunoblotting. The adhesion of leukocytes to HCAECs was evaluated by adhesion assays. Endothelial–mesenchymal transition (EndMT) induced by rapamycin treatment was evaluated by real-time PCR analysis and immunostaining for EndMT markers. Finally, we checked the activation of autophagy by immunoblotting and examined its contribution to EndMT by using a specific inhibitor. Furthermore, we examined how the activation of autophagy influences TGF-β signaling by immunoblotting for Smad2/3 and Smad7. Results A decrease in SA-β-Gal activity and the suppression of SASP factors were observed in HCAECs undergoing stress-induced premature senescence (SIPS) after rapamycin treatment. In contrast, ICAM-1 and ganglioside GM1 were upregulated by rapamycin treatment. In addition, leukocyte adhesion to HCAECs was promoted by this treatment. In rapamycin-treated HCAECs, morphological changes and the promotion of EndMT were also observed. Furthermore, we found that autophagy activation induced by rapamycin treatment, which led to activation of the TGF-β pathway, contributed to EndMT induction. Conclusions We revealed that although rapamycin functions to inhibit senescence and suppress SASP in HCAECs undergoing SIPS, EndMT is induced due to the activation of autophagy.

Suppression of replicative senescence by rapamycin in rodent embryonic cells

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

The Effect of Rapamycin on DNA Synthesis in Multiple Tissues from Late Gestation Fetal and Postnatal Rats

Chronic exposure to rapamycin and episodic serum starvation modulate ageing of human fibroblasts in vitro

Rapamycin promotes endothelial–mesenchymal transition during stress-induced premature senescence through the activation of autophagy

Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin

Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Cell senescence, rapamycin and hyperfunction theory of aging

Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

Characterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice

Inhibition of mTOR pathway decreases the expression of pre‐meiotic and meiotic markers throughout postnatal development and in adult testes in mice

Effects of low-dose rapamycin on lymphoid organs of mice prone and resistant to accelerated senescence

Rapamycin-mediated mTOR inhibition impairs silencing of sex chromosomes and the pachytene piRNA pathway in the mouse testis

Uncharacterized yeast gene YBR238C , an effector of TORC1 signaling in a mitochondrial feedback loop, accelerates cellular aging via HAP4 - and RMD9 -dependent mechanisms

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

Rapamycin Attenuates H2O2-Induced Oxidative Stress-Related Senescence in Human Skin Fibroblasts

The mTORC1-autophagy pathway is a target for senescent cell elimination

Inhibition of S6K lowers age-related inflammation and increases lifespan through the endolysosomal system

Distinct and Additive Effects of Calorie Restriction and Rapamycin in Aging Skeletal Muscle